GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

about

Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy.

P2860

Q55468487-CB6A269F-E630-48D4-9BDD-09225C14F8DF

P2860

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

Item

http://www.wikidata.org/entity/Q42617646

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

@en

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

@nl

type

Item

label

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

@en

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

@nl

prefLabel

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

@en

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

@nl

P1476

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

@en

P2093

Irina Shalaurova

http://www.w3.org/2001/XMLSchema#string

James D Otvos

http://www.w3.org/2001/XMLSchema#string

Margery A Connelly

http://www.w3.org/2001/XMLSchema#string

Martin P Playford

http://www.w3.org/2001/XMLSchema#string

Nehal N Mehta

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons

Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer

Acute-phase proteins and other systemic responses to inflammation

Assignment of resonances for 'acute-phase' glycoproteins in high resolution proton NMR spectra of human blood plasma

Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis.

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.

The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies.

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

Time variability of C-reactive protein: implications for clinical risk stratification.

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

P2888

s12967-017-1321-6

P304

219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S12967-017-1321-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092410550

http://www.w3.org/2001/XMLSchema#string

P698

29078787

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

cardiovascular disease

biomarker

P932

5658936

http://www.w3.org/2001/XMLSchema#string

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

about

P2860

P2860

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932